Heterozygous FMN2 missense variant found in a family case of premature ovarian insufficiency
Jie Li(Central South University), Xiaobo Shi(Central South University), Xue Wu(University of California, San Francisco), Ming‐Hua Zeng(Guangxi Normal University), Le Wang(Rutgers, The State University of New Jersey), Hang-Jing Tan(Central South University), Ruping Quan(Central South University), Panpan Long(Central South University), Tianliu Peng(Central South University), Junting Yang(Peking University), Hong‐Mei Xiao(Central South University)
Cited by 5
Related Papers
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity
|ACS Medicinal Chemistry Letters|2014|331
Mutant ZP1 in Familial Infertility
|New England Journal of Medicine|2014|168
Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
|Journal of Medicinal Chemistry|2015|152
Accurate recognition of colorectal cancer with semi-supervised deep learning on pathological images
|Nature Communications|2021|145